Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity

被引:259
作者
Pietra, Gabriella [2 ,3 ]
Manzini, Claudia [2 ,3 ]
Rivara, Silvia [2 ,3 ]
Vitale, Massimo [4 ]
Cantoni, Claudia [1 ,2 ,3 ]
Petretto, Andrea [1 ]
Balsamo, Mirna [1 ]
Conte, Romana [4 ]
Benelli, Roberto [4 ]
Minghelli, Simona [5 ]
Solari, Nicola [4 ]
Gualco, Marina [4 ]
Queirolo, Paola [4 ]
Moretta, Lorenzo [1 ]
Mingari, Maria Cristina [2 ,3 ,4 ]
机构
[1] Ist Giannina Gaslini, Largo G Gaslini 5, I-16147 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy
[3] Univ Genoa, Ctr Eccellenza Ric Biomed, Genoa, Italy
[4] IRCCS AOU San Martino IST, Genoa, Italy
[5] Ctr Biotecnol Avanzate, Genoa, Italy
关键词
NK CELLS; INDOLEAMINE 2,3-DIOXYGENASE; PROGNOSTIC-SIGNIFICANCE; T-CELLS; NKG2D; CANCER; CYTOTOXICITY; IMMUNOTHERAPY; LIGANDS; DNAM-1;
D O I
10.1158/0008-5472.CAN-11-2544
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Natural killer (NK) cells play a key role in tumor immune surveillance. However, adoptive immunotherapy protocols using NK cells have shown limited clinical efficacy to date, possibly due to tumor escape mechanisms that inhibit NK cell function. In this study, we analyzed the effect of coculturing melanoma cells and NK cells on their phenotype and function. We found that melanoma cells inhibited the expression of major NK receptors that trigger their immune function, including NKp30, NKp44, and NKG2D, with consequent impairment of NK cell-mediated cytolytic activity against various melanoma cell lines. This inhibitory effect was primarily mediated by indoleamine 2,3-dioxygenase (IDO) and prostaglandin E2 (PGE2). Together, our findings suggest that immunosuppressive barriers erected by tumors greatly hamper the antitumor activity of human NK cells, thereby favoring tumor outgrowth and progression. Cancer Res; 72(6) 1407-15. (C) 2012 AACR,
引用
收藏
页码:1407 / 1415
页数:9
相关论文
共 49 条
[1]
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity [J].
Balsamo, Mirna ;
Scordamaglia, Francesca ;
Pietra, Gabriella ;
Manzini, Claudia ;
Cantoni, Claudia ;
Boitano, Monica ;
Queirolo, Paola ;
Vermi, William ;
Facchetti, Fabio ;
Moretta, Alessandro ;
Moretta, Lorenzo ;
Mingari, Maria Cristina ;
Vitale, Massimo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (49) :20847-20852
[2]
IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops [J].
Barzegar, C ;
Meazza, R ;
Pereno, R ;
Pottin-Clemenceau, C ;
Scudeletti, M ;
Brouty-Boyé, D ;
Doucet, C ;
Taoufik, Y ;
Ritz, J ;
Musselli, C ;
Mishal, Z ;
Jasmin, C ;
Indiveri, F ;
Ferrini, S ;
Azzarone, B .
ONCOGENE, 1998, 16 (19) :2503-2512
[3]
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[4]
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule [J].
Bottino, C ;
Castriconi, R ;
Pende, D ;
Rivera, P ;
Nanni, M ;
Carnemolla, B ;
Cantoni, C ;
Grassi, J ;
Marcenaro, S ;
Reymond, N ;
Vitale, M ;
Moretta, L ;
Lopez, M ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (04) :557-567
[5]
Cellular ligands of activating NK receptors [J].
Bottino, C ;
Castriconi, R ;
Moretta, L ;
Moretta, A .
TRENDS IN IMMUNOLOGY, 2005, 26 (04) :221-226
[6]
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans [J].
Brandt, Cameron S. ;
Baratin, Myriam ;
Yi, Eugene C. ;
Kennedy, Jacob ;
Gao, Zeren ;
Fox, Brian ;
Haldeman, Betty ;
Ostrander, Craig D. ;
Kaifu, Tomonori ;
Chabannon, Christian ;
Moretta, Alessandro ;
West, Robert ;
Xu, WenFeng ;
Vivier, Eric ;
Levin, Steven D. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (07) :1495-1503
[7]
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival [J].
Brody, Jonathan R. ;
Costantino, Christina L. ;
Berger, Adam C. ;
Sato, Takami ;
Lisanti, Michael P. ;
Yeo, Charles J. ;
Emmons, Robert V. ;
Witkiewicz, Agnieszka K. .
CELL CYCLE, 2009, 8 (12) :1930-1934
[8]
Activation, coactivation, and costimulation of resting human natural killer cells [J].
Bryceson, Yenan T. ;
March, Michael E. ;
Ljunggren, Hans-Gustaf ;
Long, Eric O. .
IMMUNOLOGICAL REVIEWS, 2006, 214 :73-91
[9]
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56BrightCD16- cells and display an impaired capability to kill tumor cells [J].
Carrega, Paolo ;
Morandi, Barbara ;
Costa, Roberta ;
Frumento, Guido ;
Forte, Giuseppe ;
Altavilla, Giuseppe ;
Ratto, Giovanni Battista ;
Mingari, Maria Cristina ;
Moretta, Lorenzo ;
Ferlazzo, Guido .
CANCER, 2008, 112 (04) :863-875
[10]
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells [J].
Castriconi, R ;
Cantoni, C ;
Della Chiesa, M ;
Vitale, M ;
Marcenaro, E ;
Conte, R ;
Biassoni, R ;
Bottino, C ;
Moretta, L ;
Moretta, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4120-4125